Coltac Therapeutics
PrivateLast Round
Seed
Apr 1, 2022
Company Overview
Coltac Therapeutics is a biotechnology company that develops a proprietary bacteria-based screening platform for the discovery of novel molecular glues for targeted protein degradation in oncology and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coltac Therapeutics Comparables
Compare Coltac Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenAces Biosciences | 89% | |
| Magnet Biomedicine | 85% | |
| Degron Therapeutics | 85% | |
Coltac Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2022 |
Coltac Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed |
| aMoon | Seed |
| Ramot at Tel Aviv University | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2025
Grew 43% QoQ from 7 to 10 employees.
Coltac Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Coltac Therapeutics's valuation, stock price, and market status.